Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies

BACKGROUND: We systematically reviewed the literature to answer the following research questions: 1) does IL-6 (receptor) antagonist therapy reduce mortality in COVID-19 patients compared to patients not treated with IL-6 (receptor) antagonists and 2) is there an increased risk of side effects in CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Malgie, Jishnu, Schoones, Jan W, Pijls, Bart G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543350/
https://www.ncbi.nlm.nih.gov/pubmed/32964913
http://dx.doi.org/10.1093/cid/ciaa1445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543350/
https://www.ncbi.nlm.nih.gov/pubmed/32964913
http://dx.doi.org/10.1093/cid/ciaa1445

Ejemplares similares